Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abpro Holdings Inc. stock logo
ABP
Abpro
$0.22
-2.3%
$0.22
$0.15
$13.00
$13.50MN/A6.42 million shs9.12 million shs
GT Biopharma, Inc. stock logo
GTBP
GT Biopharma
$1.99
-1.5%
$2.69
$1.72
$4.10
$6.51M1.48249,467 shs38,562 shs
LakeShore Biopharma Co., Ltd. stock logo
LSB
LakeShore Biopharma
$1.19
+10.2%
$1.05
$0.87
$8.60
$9.68M0.5889,882 shs126,557 shs
Mural Oncology PLC stock logo
MURA
Mural Oncology
$2.45
-1.2%
$2.57
$0.95
$4.74
$42.31M3.031.28 million shs125,435 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abpro Holdings Inc. stock logo
ABP
Abpro
+11.43%+14.81%+8.86%-14.91%+22,719,900.00%
GT Biopharma, Inc. stock logo
GTBP
GT Biopharma
-1.94%-5.61%-33.77%-6.48%-26.55%
LakeShore Biopharma Co., Ltd. stock logo
LSB
LakeShore Biopharma
+3.84%-2.70%+10.20%-20.30%-77.95%
Mural Oncology PLC stock logo
MURA
Mural Oncology
-0.80%-2.36%+1.22%-8.82%-27.70%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abpro Holdings Inc. stock logo
ABP
Abpro
N/AN/AN/AN/AN/AN/AN/AN/A
GT Biopharma, Inc. stock logo
GTBP
GT Biopharma
1.4002 of 5 stars
3.81.00.00.00.60.00.6
LakeShore Biopharma Co., Ltd. stock logo
LSB
LakeShore Biopharma
0.3631 of 5 stars
0.03.00.00.00.60.80.6
Mural Oncology PLC stock logo
MURA
Mural Oncology
3.3701 of 5 stars
3.35.00.00.02.21.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abpro Holdings Inc. stock logo
ABP
Abpro
3.00
Buy$4.001,701.80% Upside
GT Biopharma, Inc. stock logo
GTBP
GT Biopharma
3.50
Strong Buy$11.00452.76% Upside
LakeShore Biopharma Co., Ltd. stock logo
LSB
LakeShore Biopharma
0.00
N/AN/AN/A
Mural Oncology PLC stock logo
MURA
Mural Oncology
2.50
Moderate Buy$12.00389.80% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abpro Holdings Inc. stock logo
ABP
Abpro
$180K74.97N/AN/A($0.29) per share-0.77
GT Biopharma, Inc. stock logo
GTBP
GT Biopharma
N/AN/AN/AN/A($0.75) per shareN/A
LakeShore Biopharma Co., Ltd. stock logo
LSB
LakeShore Biopharma
$80.82MN/AN/AN/A$8.86 per shareN/A
Mural Oncology PLC stock logo
MURA
Mural Oncology
N/AN/AN/AN/A$8.22 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abpro Holdings Inc. stock logo
ABP
Abpro
-$7.23MN/A0.00N/AN/AN/A-198.95%N/A
GT Biopharma, Inc. stock logo
GTBP
GT Biopharma
-$13.16M-$5.69N/AN/AN/AN/A-1,033.08%-223.20%8/13/2025 (Estimated)
LakeShore Biopharma Co., Ltd. stock logo
LSB
LakeShore Biopharma
-$61.09MN/A0.00N/AN/AN/AN/A8/21/2025 (Estimated)
Mural Oncology PLC stock logo
MURA
Mural Oncology
-$128.51M-$7.67N/AN/AN/AN/A-83.39%-70.70%8/12/2025 (Estimated)

Latest GTBP, MURA, LSB, and ABP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
GT Biopharma, Inc. stock logo
GTBP
GT Biopharma
-$0.68N/AN/AN/AN/AN/A
8/12/2025N/A
Mural Oncology PLC stock logo
MURA
Mural Oncology
-$1.13N/AN/AN/AN/AN/A
5/15/2025N/A
Abpro Holdings Inc. stock logo
ABP
Abpro
N/A-$0.08N/A-$0.08N/AN/A
5/15/2025Q1 2025
GT Biopharma, Inc. stock logo
GTBP
GT Biopharma
-$0.64-$0.76-$0.12-$0.33N/AN/A
5/14/2025Q1 2025
Mural Oncology PLC stock logo
MURA
Mural Oncology
-$2.12-$1.93+$0.19-$1.93N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abpro Holdings Inc. stock logo
ABP
Abpro
N/AN/AN/AN/AN/A
GT Biopharma, Inc. stock logo
GTBP
GT Biopharma
N/AN/AN/AN/AN/A
LakeShore Biopharma Co., Ltd. stock logo
LSB
LakeShore Biopharma
N/AN/AN/AN/AN/A
Mural Oncology PLC stock logo
MURA
Mural Oncology
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abpro Holdings Inc. stock logo
ABP
Abpro
N/A
0.11
0.11
GT Biopharma, Inc. stock logo
GTBP
GT Biopharma
N/A
0.73
0.73
LakeShore Biopharma Co., Ltd. stock logo
LSB
LakeShore Biopharma
N/AN/AN/A
Mural Oncology PLC stock logo
MURA
Mural Oncology
N/A
5.08
5.08

Institutional Ownership

CompanyInstitutional Ownership
Abpro Holdings Inc. stock logo
ABP
Abpro
23.30%
GT Biopharma, Inc. stock logo
GTBP
GT Biopharma
8.15%
LakeShore Biopharma Co., Ltd. stock logo
LSB
LakeShore Biopharma
52.64%
Mural Oncology PLC stock logo
MURA
Mural Oncology
80.21%

Insider Ownership

CompanyInsider Ownership
Abpro Holdings Inc. stock logo
ABP
Abpro
20.80%
GT Biopharma, Inc. stock logo
GTBP
GT Biopharma
3.40%
LakeShore Biopharma Co., Ltd. stock logo
LSB
LakeShore Biopharma
N/A
Mural Oncology PLC stock logo
MURA
Mural Oncology
2.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abpro Holdings Inc. stock logo
ABP
Abpro
1560.79 million48.14 millionN/A
GT Biopharma, Inc. stock logo
GTBP
GT Biopharma
83.27 million3.16 millionNo Data
LakeShore Biopharma Co., Ltd. stock logo
LSB
LakeShore Biopharma
773N/AN/AN/A
Mural Oncology PLC stock logo
MURA
Mural Oncology
11917.27 million16.89 millionOptionable

Recent News About These Companies

Minneapolis muralist honors Tuskegee airmen
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
BlackRock discloses 1.64% stake in Mural Oncology
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
BlackRock discloses 1.39% stake in Mural Oncology
BlackRock discloses stake in Mural Oncology plc
BlackRock discloses stake in Mural Oncology
FORM 8.1(a) & (b) - Mural Oncology plc

New MarketBeat Followers Over Time

Media Sentiment Over Time

Abpro stock logo

Abpro NASDAQ:ABP

$0.22 -0.01 (-2.29%)
As of 04:00 PM Eastern

Abpro Holdings Inc. is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc., formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.

GT Biopharma stock logo

GT Biopharma NASDAQ:GTBP

$1.99 -0.03 (-1.49%)
Closing price 04:00 PM Eastern
Extended Trading
$1.98 0.00 (-0.25%)
As of 05:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate that is in Phase I clinical trial for the treatment of myelodysplastic syndromes, refractory/relapsed acute myeloid leukemia or advanced systemic mastocytosis, and CD33+ malignancies. The company is developing GTB-3650, which is in preclinical studies that target CD33 on the surface of myeloid leukemias; and GTB-5550 that is in preclinical studies for treating patients with B7-H3 positive solid tumors. GT Biopharma, Inc. has a co-development partnership agreement with Altor BioScience Corporation for the clinical development of a 161533 (GTB-3550) TriKE fusion protein for cancer therapies; and a license agreement with the Regents of the University of Minnesota to develop and commercialize cancer therapies using TriKE technology. The company was formerly known as OXIS International, Inc. and changed its name to GT Biopharma, Inc. in July 2017. GT Biopharma, Inc. was incorporated in 1965 and is based in Brisbane, California.

LakeShore Biopharma stock logo

LakeShore Biopharma NASDAQ:LSB

$1.19 +0.11 (+10.19%)
Closing price 03:59 PM Eastern
Extended Trading
$1.16 -0.02 (-2.10%)
As of 05:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LakeShore Biopharma Co., Ltd. engages in the provision of discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People's Republic of China and Other Countries or Regions. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in Beijing, China.

Mural Oncology stock logo

Mural Oncology NASDAQ:MURA

$2.45 -0.03 (-1.21%)
Closing price 04:00 PM Eastern
Extended Trading
$2.50 +0.05 (+1.88%)
As of 04:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company is also developing engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.